133 related articles for article (PubMed ID: 19494396)
1. Haematopoietic stem cell transplantation for thalassaemia in Chinese patients.
Li CK; Lee V; Shing MM; Leung TF
Hong Kong Med J; 2009 Jun; 15(3 Suppl 3):39-41. PubMed ID: 19494396
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
[TBL] [Abstract][Full Text] [Related]
3. Unrelated donor haematopoietic stem cell transplantation for adult patients with haematological malignancies.
Huang H; Lai XY
Hong Kong Med J; 2009 Jun; 15(3 Suppl 3):22-6. PubMed ID: 19494392
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation for thalassemia.
Elborai Y; Uwumugambi A; Lehmann L
Immunotherapy; 2012 Sep; 4(9):947-56. PubMed ID: 23046238
[TBL] [Abstract][Full Text] [Related]
5. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.
Shenoy S; Thompson AA
Ann N Y Acad Sci; 2016 Mar; 1368(1):122-6. PubMed ID: 26999376
[TBL] [Abstract][Full Text] [Related]
6. Advances in the allogeneic transplantation for thalassemia.
Lucarelli G; Gaziev J
Blood Rev; 2008 Mar; 22(2):53-63. PubMed ID: 18039551
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic Stem Cell Transplantation in Thalassemia.
Algeri M; Lodi M; Locatelli F
Hematol Oncol Clin North Am; 2023 Apr; 37(2):413-432. PubMed ID: 36907612
[TBL] [Abstract][Full Text] [Related]
8. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
9. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
[TBL] [Abstract][Full Text] [Related]
10. A more immunosuppressive pre-transplant conditioning may be required for Chinese patients with thalassaemia.
Shing MM; Yuen PM; Li CK; Chik KW; Lai HD; Tsang KS; Ng MH; Tsoi WC
Bone Marrow Transplant; 1996 Jun; 17(6):907-10. PubMed ID: 8807092
[TBL] [Abstract][Full Text] [Related]
11. Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia.
Isgrò A; Gaziev J; Sodani P; Lucarelli G
Ann N Y Acad Sci; 2010 Aug; 1202():149-54. PubMed ID: 20712786
[TBL] [Abstract][Full Text] [Related]
12. French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
Galambrun C; Pondarré C; Bertrand Y; Loundou A; Bordigoni P; Frange P; Lutz P; Mialou V; Rubie H; Socié G; Schneider P; Bernaudin F; Paillard C; Michel G; Badens C; Thuret I; ;
Biol Blood Marrow Transplant; 2013 Jan; 19(1):62-8. PubMed ID: 22892550
[TBL] [Abstract][Full Text] [Related]
13. Haematopoietic stem cell transplantation for thalassaemia major in Hong Kong: prognostic factors and outcome.
Li CK; Shing MM; Chik KW; Lee V; Leung TF; Cheung AY; Yuen MP
Bone Marrow Transplant; 2002 Jan; 29(2):101-5. PubMed ID: 11850702
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation for thalassemia major.
Mathews V; Srivastava A; Chandy M
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1187-200. PubMed ID: 25459187
[TBL] [Abstract][Full Text] [Related]
16. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. The second mini-transplant for unstable mixed chimerism within the first 100 days after hematopoietic stem cell transplant in severe thalassemia.
Choeyprasert W; Pakakasama S; Anurathapan U; Songdej D; Sirachainun N; Sirireung S; Panthangkool W; Hongeng S
Pediatr Transplant; 2012 Sep; 16(6):E238-40. PubMed ID: 21895905
[TBL] [Abstract][Full Text] [Related]
19. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic cellular gene therapy for hemoglobinopathies.
Gaziev J; Lucarelli G
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
